This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Elliott International sells all its shares in German drugmaker Stada

( February 14, 2018, 10:54 GMT | Official Statement) -- MLex Summary: Elliott International has sold the last of its stake in Stada Arzneimittel and no longer holds any voting rights in the generic drugmaker, according a notice published by the German company today. The Cayman Islands-based arm of Paul Singer's Elliott hedge fund had previously reported a holding of 7.75 percent, the notice says. Stada is being acquired by buyout firms Bain Capital and Cinven, which agreed in September to pay Elliott and other investors a higher price for their holdings.Full filing attached below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login